MARS Bioimaging Mobile Photon-counting CT Scanner Selected for Contrast Agent and AI Research
The system will support the development of new contrast agents and AI-enabled imaging at a research center in Italy.
The system will support the development of new contrast agents and AI-enabled imaging at a research center in Italy.
The program expansion includes two additional Da Vinci Xi models cleared by the Food and Drug Administration and the opening of new repair facilities in Texas and Arizona.
The acquisition is expected to broaden GE HealthCare’s cloud and AI imaging tools and extend its reach into outpatient workflows.
The system will support the development of new contrast agents and AI-enabled imaging at a research center in Italy.
The new entity combines capabilities in system design, microelectronics, precision molding, and advanced manufacturing for medical device OEMs.
Read MoreThe new COO is responsible for advancing the company’s portfolio of tech-enabled solutions designed to improve asset uptime, reduce costs, and strengthen the capacity and efficiency of provider operations.
Read MoreThe move offers hospitals a new procurement and deployment channel for SaaS-based imaging software designed to improve workflow and data access.
Read MoreThe clinical asset management company ranked No 45 on the list, recognized for its company culture and employee experience.
Read MoreThe eight-year agreement aims to improve patient access and clinical productivity with advanced, multi-modality imaging equipment.
Read MoreThe expanded commitment will supply additional medical technologies, including ultrasound systems, to the nonprofit’s hospital ships providing surgical care in Africa.
Read More
The investment enhances reLink’s ability to provide localized support to healthcare providers throughout Florida and the Southeastern United States.